Diagnostic Test for H pylori

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 5 No 8
Volume 5
Issue 8

TUSTIN, Ca--AMDL, Inc. has filed a 510(k) Premarket Notification with the FDA for PyloriProbe, its diagnostic test for the detection of Heli-cobacter pylori. This bacterium is associated with chronic gastritis and gastric and duodenal ulcers, and has been classified by WHO as a class I carcinogen that increases the risk of developing stomach cancer. Pylori-Probe is a direct enzyme immunoassay (EIA) that detects the presence of H pylori antibodies in serum samples.

TUSTIN, Ca--AMDL, Inc. has filed a 510(k) Premarket Notificationwith the FDA for PyloriProbe, its diagnostic test for the detectionof Heli-cobacter pylori. This bacterium is associated withchronic gastritis and gastric and duodenal ulcers, and has beenclassified by WHO as a class I carcinogen that increases the riskof developing stomach cancer. Pylori-Probe is a direct enzymeimmunoassay (EIA) that detects the presence of H pyloriantibodies in serum samples.

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Recent Videos
Multidisciplinary care can help ensure that treatment planning does not deviate from established guidelines for inflammatory breast cancer management.
4 experts in this video
2 experts in this video
2 experts in this video
4 experts in this video
A study aimed to determine the variables that correlated with extravasation rates in patients receiving radiation injection therapy.
Related Content